Peptide Glossary
Reviewed by the Rite Aid Health Team · Last updated July 2, 2026
When a peptide term gets technical, use the definition to make the next decision clearer: route, dose math, lab tracking, evidence, and how the peptide signals in the body.
Almost done
Confirm your email to secure 20% off your first compounded-peptide order. We'll notify you when consultations and ordering open.
Get 20% off your first compounded-peptide order
Join the early-access waitlist and we'll notify you the moment consultations and ordering open.
A
- Agonist
- A compound that activates a receptor and turns on its signal. Agonists can copy a natural signal, strengthen it, or make it last longer than the body's own short-lived messenger.
- Why it matters: GLP-1 medicines are receptor agonists. PT-141 is a melanocortin-receptor agonist.
- See also: PT-141 Weight-loss peptides
- Amino acid
- A building block of proteins and peptides. Amino acids join in a set order, and that order helps determine the peptide's shape, stability, and target in the body.
- Why it matters: A peptide is a short chain of amino acids linked together in a specific order.
- Analog
- A modified version of a natural peptide or hormone. The change may make the molecule last longer, resist breakdown, bind differently, or become practical as a medication.
- Why it matters: An analog may last longer, bind a receptor more selectively, or be easier to use as a medicine.
- See also: Sermorelin Tesamorelin
- Antagonist
- A compound that blocks a receptor or reduces its signal. An antagonist can sit on the receptor without turning it on, which can prevent another signal from activating that pathway.
- Why it matters: It is the opposite of an agonist. Most peptides discussed here are not antagonists, but the term helps you understand receptor language.
B
- Bacteriostatic water
- Sterile water with a preservative, usually benzyl alcohol, used to mix many multi-dose peptide vials. It is different from plain sterile water because it is intended for repeated vial punctures when used correctly.
- Why it matters: The preservative helps limit bacterial growth after the vial has been punctured.
- See also: Reconstitution guide Peptide calculator
- Bioavailability
- How much of a compound reaches circulation in a usable form. Poor bioavailability means a large amount may be swallowed, sprayed, or applied, but only a smaller amount reaches the bloodstream or target tissue.
- Why it matters: Route matters. A peptide taken by mouth may break down in digestion, while an injection can bypass that problem.
- Biomarker
- A measurable lab value that gives information about a body process. Biomarkers do not tell the whole story, but they can show direction, safety signals, and whether a pathway is changing.
- Why it matters: IGF-1, hs-CRP, liver enzymes, kidney markers, glucose, and lipids can help track peptide response and safety.
- See also: Blood work for peptide users
- Body composition
- The mix of fat, lean mass, water, and other tissue in the body. Scale weight alone can miss important changes, especially when water retention, fat loss, and lean mass change at the same time.
- Why it matters: Growth-hormone-axis peptides are usually discussed in terms of recovery and body composition rather than direct muscle gain.
- See also: Muscle and performance peptides
C
- Cadence
- How often a peptide is taken. Cadence can mean daily, several times per week, weekly, or another schedule, depending on half-life, tolerability, and the clinical goal.
- Why it matters: A short half-life may mean more frequent dosing. A long-acting analog may be used less often.
- Compounding pharmacy
- A licensed pharmacy that prepares medication for a specific patient when a prescriber orders it. Compounding can change dose form, strength, or ingredients, but it is not the same thing as an FDA-approved manufactured product.
- Why it matters: Many non-FDA-approved peptide products, when legally available, depend on prescription compounding rather than a mass-market brand drug.
- Concentration
- How much peptide is dissolved in each milliliter of liquid, usually written as mg/mL. The same vial can have a higher or lower concentration depending on how much water is added during reconstitution.
- Why it matters: Concentration determines how many syringe units you draw for a target dose.
- See also: Peptide calculator
- Cycle
- A planned period of peptide use, followed by a stop point or reassessment. A cycle should have a purpose, a timeframe, and a way to decide whether continuing makes sense.
- Why it matters: Some protocols are run in short cycles. Others are managed longer term under a clinician.
D
- DAC
- Drug affinity complex, a modification used with some CJC-1295 formulations to extend duration. DAC helps the peptide bind to albumin in the blood, slowing clearance and changing the dosing pattern.
- Why it matters: CJC-1295 with DAC lasts longer than CJC-1295 without DAC, which changes dosing cadence and the shape of the GH signal.
- See also: CJC-1295
- Dose
- The amount of peptide you intend to take at one time. Dose is usually written in milligrams or micrograms, while the syringe shows volume in units or milliliters.
- Why it matters: Dose is not the same as volume. The calculator converts a target dose into syringe units based on vial size and water added.
- See also: Peptide calculator
- Downstream effect
- A later effect that happens after a receptor or pathway is activated. Downstream effects can be useful, unwanted, delayed, or indirect, which is why receptor language does not always predict the full experience.
- Why it matters: A peptide may bind one receptor but affect appetite, collagen production, inflammation, or hormone release downstream.
F
- FDA-approved
- Reviewed and approved by the FDA for a specific indication, dose form, and use. Approval applies to that product and labeled use; it does not automatically cover every compounded version, research product, or off-label protocol.
- Why it matters: PT-141, tesamorelin, semaglutide, and tirzepatide have approved drug pathways. Many research peptides do not.
- See also: PT-141 Tesamorelin
G
- GHRH
- Growth-hormone-releasing hormone, the natural signal that tells the pituitary to release growth hormone. It is part of the hypothalamus-pituitary growth-hormone axis, which also affects IGF-1 downstream.
- Why it matters: Sermorelin, tesamorelin, and CJC-1295 are modeled on this pathway.
- See also: Sermorelin
- GHRH analog
- A peptide modeled on growth-hormone-releasing hormone. GHRH analogs are designed to push the pituitary through a familiar signal rather than directly supplying growth hormone.
- Why it matters: GHRH analogs support the body's own GH release rather than replacing growth hormone directly.
- See also: Tesamorelin vs Sermorelin
- GHRP
- Growth-hormone-releasing peptide. GHRPs work through secretagogue pathways that stimulate GH release, often discussed alongside GHRH analogs because the signals are related but not identical.
- Why it matters: GHRPs help trigger a growth-hormone pulse. Ipamorelin is the common example in this section.
- See also: Ipamorelin
- GH secretagogue
- A compound that causes the body to release more of its own growth hormone. Secretagogues rely on the body's remaining ability to produce and pulse GH, so they are different from replacement therapy.
- Why it matters: Ipamorelin and MK-677 are secretagogues. They are not the same as injecting growth hormone.
- See also: Ipamorelin MK-677
- GIP
- Glucose-dependent insulinotropic polypeptide, an incretin hormone involved in insulin and metabolic signaling. It is released around meals and is part of the gut-pancreas communication system.
- Why it matters: Tirzepatide targets both GLP-1 and GIP receptors.
- See also: Semaglutide vs Tirzepatide
- GLP-1
- Glucagon-like peptide-1, an incretin hormone involved in appetite, insulin, and glucose regulation. GLP-1 signaling slows gastric emptying, supports glucose-dependent insulin release, and affects appetite centers.
- Why it matters: Semaglutide and tirzepatide act through GLP-1 biology and are used for weight and metabolic care.
- See also: Weight-loss peptides
- Glucagon
- A hormone involved in blood sugar and energy use. Glucagon generally pushes the liver to release stored energy, which makes it biologically different from GLP-1 and GIP even when they are discussed together.
- Why it matters: Retatrutide is called a triple agonist because it targets GLP-1, GIP, and glucagon receptors.
- See also: Tirzepatide vs Retatrutide
Almost done
Confirm your email to secure 20% off your first compounded-peptide order. We'll notify you when consultations and ordering open.
Get 20% off your first compounded-peptide order
Join the early-access waitlist and we'll notify you the moment consultations and ordering open.
H
- Half-life
- How long it takes for the amount of a compound in the body to fall by half. It is an estimate, not a timer; absorption, clearance, dose form, and individual biology can all change the real-world curve.
- Why it matters: Half-life helps explain whether a peptide is short-acting or long-acting and how often it may be used.
- See also: Peptide half-lives guide
- hs-CRP
- High-sensitivity C-reactive protein, a blood marker of inflammation. It is not specific to one injury or disease, but it can help show whether systemic inflammation is moving up or down.
- Why it matters: It can be useful when tracking inflammatory or recovery-focused goals.
- See also: Healing and recovery peptides
I
- IGF-1
- Insulin-like growth factor 1, a blood marker tied to growth-hormone activity. The liver produces much of the circulating IGF-1 response after GH signaling, so it is often used as the practical readout for GH-axis peptides.
- Why it matters: IGF-1 is the main lab used to see whether a GH-axis peptide is having the intended effect.
- See also: IGF-1 blood test
- Indication
- The specific condition or use a drug is approved or prescribed for. Indication matters because evidence, dosing, warnings, and insurance coverage are usually tied to a defined use.
- Why it matters: An FDA approval is tied to an indication. A peptide may be approved for one use and discussed off-label for another.
- Intranasal
- Given through the nose, usually as a spray or drops. Intranasal delivery is used when the goal is local nasal absorption or a route that avoids digestion, but absorption can be variable.
- Why it matters: Some cognitive peptides, such as Semax, are commonly discussed in intranasal form.
- See also: Semax
L
- Lyophilized
- Freeze-dried. Lyophilization removes water to make a powder that is usually more stable for storage than a mixed liquid.
- Why it matters: Many peptide vials arrive as lyophilized powder and must be reconstituted before use.
- See also: Reconstitution guide
M
- Melanocortin
- A family of receptors involved in pigmentation, appetite, sexual function, and other central signals. Different melanocortin receptors do different jobs, so the receptor subtype matters.
- Why it matters: PT-141 acts on melanocortin pathways, which is why it is discussed separately from blood-flow drugs.
- See also: PT-141
- Mitochondrial peptide
- A peptide connected to mitochondrial signaling or metabolism. These peptides are discussed around energy handling, cellular stress, and metabolic function rather than a single hormone pathway.
- Why it matters: MOTS-c is discussed as a mitochondrial-derived peptide for metabolic function.
- See also: MOTS-c
Almost done
Confirm your email to secure 20% off your first compounded-peptide order. We'll notify you when consultations and ordering open.
Get 20% off your first compounded-peptide order
Join the early-access waitlist and we'll notify you the moment consultations and ordering open.
N
- Nootropic
- A compound discussed for focus, memory, or cognitive performance. The term describes the intended use category, not proof that a compound works or is safe.
- Why it matters: Semax is usually grouped with nootropic or cognitive peptides.
- See also: Semax
O
- Off-label
- Use of an approved drug for a purpose outside its FDA-approved indication. Off-label prescribing can be legal and common, but the evidence and risk-benefit case may be weaker or different from the approved use.
- Why it matters: Off-label use should be managed by a clinician and is different from using an unapproved research product.
P
- Pathway
- The chain of biological events after a signal is triggered. A pathway can include receptors, enzymes, hormones, gene signals, and feedback loops.
- Why it matters: A peptide can start at a receptor and then affect a wider pathway such as GH release, appetite, inflammation, or collagen remodeling.
- Peptide bond
- The chemical bond that links amino acids together. Peptide bonds form the backbone of the chain, while the side groups help determine how the peptide folds and interacts.
- Why it matters: Peptide bonds are what turn individual amino acids into a peptide chain.
R
- Receptor
- A docking site on or in a cell that responds to a specific signal. Receptors help explain selectivity: a peptide can have a strong effect in tissues that carry the right receptor and little effect where that receptor is absent.
- Why it matters: When a peptide binds the right receptor, it can change what the cell does.
- Reconstitution
- Mixing freeze-dried peptide powder with a liquid so it can be measured and injected. The amount of water controls concentration, which changes the syringe volume for the same peptide dose.
- Why it matters: Reconstitution changes concentration and syringe units, not the total amount of peptide in the vial.
- See also: Peptide calculator
- Route of administration
- How a compound is taken: subcutaneous, intranasal, oral, topical, or another route. Route affects absorption, convenience, sterility needs, and which side effects are most likely.
- Why it matters: Route changes absorption, practicality, and risk.
S
- Satiety
- The feeling of fullness after eating. Satiety is not the same as nausea or food aversion; it usually means meals feel satisfying sooner or for longer.
- Why it matters: GLP-1 medicines support weight loss partly by increasing satiety and reducing appetite.
- See also: Weight-loss peptides
- Secretagogue
- A compound that causes the body to release something it already makes. In peptide discussions, the term usually refers to growth-hormone secretagogues that stimulate GH release instead of providing GH directly.
- Why it matters: Growth-hormone secretagogues prompt GH release rather than replacing GH directly.
- See also: Muscle and performance peptides
- Subcutaneous
- Injected into the fatty layer under the skin. Subcutaneous injections are usually shallower than intramuscular injections and are commonly done in the abdomen, thigh, or upper arm area.
- Why it matters: Many injectable peptides are given subcutaneously rather than into muscle or a vein.
- See also: Injection sites guide
- Syringe units
- The marks on an insulin syringe. On a U-100 syringe, 100 units equals 1 mL, so each unit equals 0.01 mL.
- Why it matters: Units are a volume measurement. The peptide dose depends on concentration.
- See also: Peptide calculator
T
- Telomerase
- An enzyme involved in maintaining telomeres, the protective ends of chromosomes. Telomerase biology is complex, and interest in it does not mean a peptide has proven anti-aging effects in humans.
- Why it matters: Epitalon is often discussed in relation to telomerase and longevity research.
- See also: Epitalon
- Topical
- Applied to the skin. Topical use is meant for local contact with skin or hair-bearing areas and should not be assumed to behave like an injection.
- Why it matters: GHK-Cu is commonly used topically in skincare products, while injectable use is a different route and risk category.
- See also: GHK-Cu
U
- U-100
- The standard insulin syringe scale where 100 units equals 1 mL. Smaller U-100 syringes still use the same math; they just make small volumes easier to see.
- Why it matters: A 1 mL, 0.5 mL, and 0.3 mL insulin syringe all use the same U-100 math; they differ by barrel capacity.
- See also: Peptide calculator
V
- Visceral fat
- Deep abdominal fat around internal organs. It is different from pinchable subcutaneous fat and is more closely tied to metabolic risk.
- Why it matters: Tesamorelin is FDA-approved for reducing excess visceral abdominal fat in people with HIV-associated lipodystrophy.
- See also: Tesamorelin
W
- Washout period
- A planned break after stopping a compound before starting another or measuring a baseline. The right length depends on half-life, downstream effects, and what you are trying to measure next.
- Why it matters: Washout periods help reduce carryover effects, especially in trials or when changing protocols.
Almost done
Confirm your email to secure 20% off your first compounded-peptide order. We'll notify you when consultations and ordering open.
Get 20% off your first compounded-peptide order
Join the early-access waitlist and we'll notify you the moment consultations and ordering open.
For general education only — not medical advice or a treatment recommendation. Peptides are not a substitute for care from a licensed provider. Talk to a qualified healthcare professional before you start, stop, or change any peptide, medication, or supplement.